- Home
- Publications
- Publication Search
- Publication Details
Title
The role of melatonin in Multiple Sclerosis
Authors
Keywords
-
Journal
NEUROLOGICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-16
DOI
10.1007/s10072-019-04137-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Melatonin attenuates TNF-α and IL-1β expression in synovial fibroblasts and diminishes cartilage degradation: implications for the treatment of rheumatoid arthritis
- (2019) Chien-Chung Huang et al. JOURNAL OF PINEAL RESEARCH
- Melatonin Therapy Modulates Cerebral Metabolism and Enhances Remyelination by Increasing PDK4 in a Mouse Model of Multiple Sclerosis
- (2019) Majid Ghareghani et al. Frontiers in Pharmacology
- Association between interleukin-4 and interleukin-10 single nucleotide polymorphisms and multiple sclerosis among Iraqi patients
- (2019) Milad A. Al-Naseri et al. NEUROLOGICAL SCIENCES
- Clinical relevance of circadian melatonin release in relapsing-remitting multiple sclerosis
- (2019) Simone Kern et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Environmental and genetic risk factors for MS: an integrated review
- (2019) Emmanuelle Waubant et al. Annals of Clinical and Translational Neurology
- Spasticity Treatment Ameliorates the Efficacy of Melatonin Therapy in Experimental Autoimmune Encephalomyelitis (EAE) Mouse Model of Multiple Sclerosis
- (2018) Majid Ghareghani et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Neuroprotective Effects of Melatonin on Experimental Allergic Encephalomyelitis Mice Via Anti-Oxidative Stress Activity
- (2018) Ting Long et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Oral supplementation of melatonin protects against lupus nephritis renal injury in a pristane-induced lupus mouse model
- (2018) Mariane dos Santos et al. LIFE SCIENCES
- Estudio comparativo de melatonina contra los tratamientos inmunomoduladores (interferón beta y acetato de glatirámero) en un modelo murino de esclerosis múltiple
- (2018) E.J. Ramos González et al. NEUROLOGIA
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Melatonin therapy reduces the risk of osteoporosis and normalizes bone formation in multiple sclerosis
- (2017) Majid Ghareghani et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Melatonin reduces inflammatory response in peripheral T helper lymphocytes from relapsing-remitting multiple sclerosis patients
- (2017) Nuria Álvarez-Sánchez et al. JOURNAL OF PINEAL RESEARCH
- Melatonin signaling in T cells: Functions and applications
- (2017) Wenkai Ren et al. JOURNAL OF PINEAL RESEARCH
- Oxidative Modification of Blood Serum Proteins in Multiple Sclerosis after Interferon Beta and Melatonin Treatment
- (2017) Monika Adamczyk-Sowa et al. Oxidative Medicine and Cellular Longevity
- Associations of melatonin receptor gene polymorphisms with Graves' disease
- (2017) Jiunn-Diann Lin et al. PLoS One
- Fatigue in Rheumatoid Arthritis
- (2017) Patricia Katz Current Rheumatology Reports
- Oxidative Stress Induced by Lipid Peroxidation Is Related with Inflammation of Demyelination and Neurodegeneration in Multiple Sclerosis
- (2017) Pin Wang et al. EUROPEAN NEUROLOGY
- Anti-inflammatory effects of melatonin in multiple sclerosis
- (2016) Mauricio F. Farez et al. BIOESSAYS
- Melatonin exacerbates acute experimental autoimmune encephalomyelitis by enhancing the serum levels of lactate: A potential biomarker of multiple sclerosis progression
- (2016) Majid Ghareghani et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Sleep Disorders in Multiple Sclerosis
- (2016) Tiffany J. Braley et al. Current Neurology and Neuroscience Reports
- Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing- Remitting Multiple Sclerosis
- (2016) Begona M. Escribano et al. CURRENT PHARMACEUTICAL DESIGN
- Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives
- (2016) Alberto Gajofatto et al. Expert Review of Neurotherapeutics
- Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis
- (2016) Shyi-Jou Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis
- (2016) Jie Wen et al. Journal of Neuroimmune Pharmacology
- Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes
- (2016) Solaleh Emamgholipour et al. LIFE SCIENCES
- Plasma melatonin levels do not differ in SLE patients
- (2016) P. Wang et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives
- (2016) Alberto Gajofatto et al. Expert Review of Neurotherapeutics
- Changes in Serum Ceruloplasmin Levels Based on Immunomodulatory Treatments and Melatonin Supplementation in Multiple Sclerosis Patients
- (2016) Monika Adamczyk-Sowa et al. MEDICAL SCIENCE MONITOR
- Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors
- (2016) Claudia Helena Marck et al. PLoS One
- Decreased Daily Melatonin Levels in Women with Systemic Lupus Erythematosus - A Short Report
- (2016) Ralitsa Robeva et al. Balkan Medical Journal
- Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque
- (2015) Josa M. Frischer et al. ANNALS OF NEUROLOGY
- Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance
- (2015) Nuria Álvarez-Sánchez et al. BRAIN BEHAVIOR AND IMMUNITY
- Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses
- (2015) Mauricio F. Farez et al. CELL
- Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis
- (2015) Martin Karlík et al. CLINICAL BIOCHEMISTRY
- Classification, diagnosis, and differential diagnosis of multiple sclerosis
- (2015) Ilana Katz Sand CURRENT OPINION IN NEUROLOGY
- Novel Observations From Next-Generation RNA Sequencing of Highly Purified Human Adult and Fetal Islet Cell Subsets
- (2015) David M. Blodgett et al. DIABETES
- Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012 – 2014)
- (2015) Silvia Rivara et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Melatonin treatment improves primary progressive multiple sclerosis: a case report
- (2015) Antonio López-González et al. JOURNAL OF PINEAL RESEARCH
- Experimental and clinical aspects of melatonin and clock genes in diabetes
- (2015) Elmar Peschke et al. JOURNAL OF PINEAL RESEARCH
- Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study
- (2015) Alfredo Damasceno et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Role of the innate and adaptive immune responses in the course of multiple sclerosis
- (2015) Bernhard Hemmer et al. LANCET NEUROLOGY
- Shift work influences multiple sclerosis risk
- (2015) AK Hedström et al. Multiple Sclerosis Journal
- Class II HLA interactions modulate genetic risk for multiple sclerosis
- (2015) Loukas Moutsianas et al. NATURE GENETICS
- Melatonin: Physiological effects in humans
- (2015) B. Claustrat et al. NEUROCHIRURGIE
- Clinical and cognitive implications of cerebrospinal fluid oligoclonal bands in multiple sclerosis patients
- (2015) Maria Anagnostouli et al. NEUROLOGICAL SCIENCES
- Shift work influences multiple sclerosis risk
- (2015) AK Hedström et al. Multiple Sclerosis Journal
- Immunology of Relapse and Remission in Multiple Sclerosis
- (2014) Lawrence Steinman Annual Review of Immunology
- Relapsing and progressive forms of multiple sclerosis
- (2014) Ranjan Dutta et al. CURRENT OPINION IN NEUROLOGY
- Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: Relationship to oxidative stress
- (2014) Carmen Bahamonde et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- New Multiple Sclerosis Phenotypic Classification
- (2014) Fred D. Lublin EUROPEAN NEUROLOGY
- Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology
- (2014) Stefano Comai et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Multiple sclerosis genetics
- (2014) Stephen Sawcer et al. LANCET NEUROLOGY
- Melatonin Acts as Antioxidant and Improves Sleep in MS Patients
- (2014) Monika Adamczyk-Sowa et al. NEUROCHEMICAL RESEARCH
- The essential role of t cells in multiple sclerosis: A reappraisal
- (2014) CrisS Constantinescu et al. Biomedical Journal
- Serum levels of melatonin and cytokines in multiple sclerosis
- (2014) Naser Farhadi et al. Biomedical Journal
- Melatonin Receptor Genes in Vertebrates
- (2013) Di Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Modulation by Melatonin of the Pathogenesis of Inflammatory Autoimmune Diseases
- (2013) Gu-Jiun Lin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression
- (2013) Ying-Hui Wu et al. JOURNAL OF AFFECTIVE DISORDERS
- Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course
- (2013) Elżbieta Miller et al. JOURNAL OF NEUROIMMUNOLOGY
- Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
- (2013) Ashley H Beecham et al. NATURE GENETICS
- Involvement of Oxidative Stress in Occurrence of Relapses in Multiple Sclerosis: The Spectrum of Oxidatively Modified Serum Proteins Detected by Proteomics and Redox Proteomics Analysis
- (2013) Ada Fiorini et al. PLoS One
- Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects
- (2013) Nikolaos A. Patsopoulos et al. PLoS Genetics
- Melatonin pathway genes are associated with progressive subtypes and disability status in multiple sclerosis among Finnish patients
- (2012) Renuka Natarajan et al. JOURNAL OF NEUROIMMUNOLOGY
- Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression
- (2012) Pedro Lourenco et al. Multiple Sclerosis Journal
- New perspectives in melatonin uses
- (2012) A. Carpentieri et al. PHARMACOLOGICAL RESEARCH
- Shift work at young age is associated with increased risk for multiple sclerosis
- (2011) Anna Karin Hedström et al. ANNALS OF NEUROLOGY
- Multiple Sclerosis: Pathogenesis and Treatment
- (2011) Ingrid Loma et al. Current Neuropharmacology
- Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis
- (2011) Lena Melamud et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- (2011) Stephen Sawcer et al. NATURE
- Pinealectomy ameliorates collagen II-induced arthritis in mice
- (2010) I. HANSSON et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors
- (2010) M. L. Dubocovich et al. PHARMACOLOGICAL REVIEWS
- Melatonin—A pleiotropic, orchestrating regulator molecule
- (2010) Rüdiger Hardeland et al. PROGRESS IN NEUROBIOLOGY
- Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target
- (2009) Kenneth L. Becker et al. BRITISH JOURNAL OF PHARMACOLOGY
- Melatonin downregulates nuclear erythroid 2-related factor 2 and nuclear factor-kappaB during prevention of oxidative liver injury in a dimethylnitrosamine model
- (2009) Kyung Hee Jung et al. JOURNAL OF PINEAL RESEARCH
- Sleep disorders in patients with multiple sclerosis
- (2009) Steven D. Brass et al. SLEEP MEDICINE REVIEWS
- A novel interplay between membrane and nuclear melatonin receptors in human lymphocytes: significance in IL-2 production
- (2008) P. J. Lardone et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Treatment with testosterone or estradiol in melatonin treated females and males MRL/MpJ-Faslprmice induces negative effects in developing systemic lupus erythematosus
- (2008) Antonio J. Jimenez-Caliani et al. JOURNAL OF PINEAL RESEARCH
- Melatonin receptor antagonist luzindole is a powerful radical scavenger in vitro
- (2008) Alexander M. Mathes et al. JOURNAL OF PINEAL RESEARCH
- Prevalence of sleep problems in individuals with multiple sclerosis
- (2008) AM Bamer et al. Multiple Sclerosis Journal
- Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis
- (2008) M. C. Ysrraelit et al. NEUROLOGY
- Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways
- (2008) S PANDIPERUMAL et al. PROGRESS IN NEUROBIOLOGY
- The association of nocturnal serum melatonin levels with major depression in patients with acute multiple sclerosis
- (2008) Zehra Akpınar et al. PSYCHIATRY RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More